Eisai
4523.T
#1922
Rank
$8.40 B
Marketcap
$29.82
Share price
-0.56%
Change (1 day)
-42.09%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Earnings for Eisai (4523.T)

Earnings in 2024 (TTM): $0.43 Billion USD

According to Eisai's latest financial reports the company's current earnings are $5.06 Billion USD. In 2023 the company made an earning of $0.52 Billion USD, an increase over its 2022 earnings that were of -$22.86 Million USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Eisai from 2009 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) $0.43 B-16.5%
2023 $0.52 B-2392.87%
2022 -$22.86 Million-103.6%
2021 $0.63 B-39.52%
2020 $1.04 B7.3%
2019 $0.97 B17.23%
2018 $0.83 B86.06%
2017 $0.44 B-23.64%
2016 $0.58 B27.28%
2015 $0.46 B22.08%
2014 $0.37 B-46.11%
2013 $0.70 B-21.67%
2012 $0.89 B-20.72%
2011 $1.13 B-8.44%
2010 $1.23 B18.85%
2009 $1.03 B